Consumer Healthcare Products Association (CHPA)
Trade associationOppose
Otc access to diphenhydramine
Citizen Petition from Robert Naclerio
FDA-2025-P-6950-0001Other
Comments
2
Last activity Jul 2, 2026
Deadline
--
Net supportiSupport minus oppose · campaigns included
-100%
-100% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Robert Naclerio
- Posted
- Dec 11, 2025
- Comment period
- Dec 11, 2025 – ?
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
-100%
Net support
Oppose2
Aggregates include form-letter campaigns. Excluding them, net support is -100% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Trade association
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Dec 11, 2025
Jan 5Jun 29
Support0Oppose2Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
0%
100%
0%
Trade association
0%
100%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Otc access to diphenhydramine |
|---|---|
Consumer Healthcare Products Association (CHPA) Trade associationOppose The Consumer Healthcare Products Association (CHPA) opposes the petition to remove diphenhydramine from the OTC Cough, C |
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- Jul 2, 2026Comment from CHPAOpposeTrade association📎 Attachment
The Consumer Healthcare Products Association (CHPA) opposes the petition to remove diphenhydramine from the OTC Cough, Cold, Allergy Monograph. They argue that diphenhydramine is a safe, effective, and widely used medication with a unique therapeutic role that lacks one-for-one substitutes, and that its removal would negatively impact consumer access and public health.
Read comment → - Jan 9, 2026Comment from Michelle Freeman-WyrickOpposeIndividual📎 Attachment
Michelle Freeman-Wyrick, a private individual from Tennessee, opposes the citizen petition to remove oral diphenhydramine from over-the-counter products. She argues that the medication is a safe, affordable, and essential self-care option and suggests that safety concerns should be managed through improved labeling and education rather than removal from the market.
Read comment →